Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

Published:2012-11 Issue:11 Volume:18 Page:2043-2055
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Sussman Daniel A.,Kubiliun Nisa,Mulani Parvez M.,Chao Jingdong,Gillis Carol A.T.,Yang Mei,Lu Mei,Abreu Maria T.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference27 articles.

1. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease

2. The Direct and Indirect Cost Burden of Crohn's Disease and Ulcerative Colitis

3. Health Care Resource Utilization in Inflammatory Bowel Disease

4. Inflammatory Bowel Disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Multiple Linear Regression Equation Models in Analyzing Factors Affecting Hospitalization Costs for Oncology Diseases;Proceedings of the 2024 3rd International Conference on Cyber Security, Artificial Intelligence and Digital Economy;2024-03

2. Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis;European Journal of Medical Research;2022-09-30

3. Adalimumab vs Infliximab in Pediatric Patients With Crohn's Disease: A Propensity Score Analysis and Predictors of Treatment Escalation;Clinical and Translational Gastroenterology;2022-04-01

4. Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission;Acta Gastro Enterologica Belgica;2021-09

5. Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease;Gut and Liver;2021-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3